tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:1801 Stock Latest News

Innovent Wins China Approval for New Jaypirca Leukemia Indication
Company AnnouncementsInnovent Wins China Approval for New Jaypirca Leukemia Indication
13h ago
Why Did Innovent Biologics Shares Surge?
PremiumMarket News
Why Did Innovent Biologics Shares Surge?
19d ago
LLY
Innovent Biologics announces collaboration with Lilly
PremiumThe Fly
Innovent Biologics announces collaboration with Lilly
19d ago
Innovent Strikes US$8.85 Billion Global Oncology and Immunology Pact With Eli Lilly
PremiumCompany Announcements
Innovent Strikes US$8.85 Billion Global Oncology and Immunology Pact With Eli Lilly
20d ago
Innovent Surpasses RMB10 Billion in 2025 Product Revenue on Oncology and Chronic Disease Momentum
PremiumCompany Announcements
Innovent Surpasses RMB10 Billion in 2025 Product Revenue on Oncology and Chronic Disease Momentum
24d ago
Innovent Wins Landmark China Approval for First Domestic CTLA-4 Neoadjuvant Colon Cancer Therapy
PremiumCompany AnnouncementsInnovent Wins Landmark China Approval for First Domestic CTLA-4 Neoadjuvant Colon Cancer Therapy
2M ago
Innovent Biologics announces initial data of IBI3003
Premium
The Fly
Innovent Biologics announces initial data of IBI3003
3M ago
Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
Premium
Company Announcements
Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
3M ago
Innovent Biologics Grants Share Options to Boost Employee Engagement
PremiumCompany Announcements
Innovent Biologics Grants Share Options to Boost Employee Engagement
3M ago
Innovent Biologics Closes Strategic Partnership with Takeda
PremiumCompany Announcements
Innovent Biologics Closes Strategic Partnership with Takeda
3M ago
Innovent Biologics enters HSI, two other major indices
PremiumThe Fly
Innovent Biologics enters HSI, two other major indices
3M ago
Innovent Biologics’ PECONDLE® Approved for Psoriasis Treatment in China
PremiumCompany Announcements
Innovent Biologics’ PECONDLE® Approved for Psoriasis Treatment in China
3M ago
Innovent’s Mazdutide 9mg Application Accepted by China’s NMPA
PremiumCompany AnnouncementsInnovent’s Mazdutide 9mg Application Accepted by China’s NMPA
3M ago
Innovent Biologics, Sanegene Bio announces results on IBI3016
Premium
The Fly
Innovent Biologics, Sanegene Bio announces results on IBI3016
4M ago
Innovent Biologics Achieves 40% Revenue Growth in Q3 2025
Premium
Company Announcements
Innovent Biologics Achieves 40% Revenue Growth in Q3 2025
4M ago
Innovent Biologics and Takeda Partnership Fuels Global Expansion and Strengthens Buy Rating
PremiumRatings
Innovent Biologics and Takeda Partnership Fuels Global Expansion and Strengthens Buy Rating
4M ago
Innovent Biologics announces global strategic partnership with Takeda
PremiumThe Fly
Innovent Biologics announces global strategic partnership with Takeda
4M ago
TAK
Innovent Biologics Partners with Takeda for Global Cancer Therapy Development
PremiumCompany Announcements
Innovent Biologics Partners with Takeda for Global Cancer Therapy Development
4M ago
Innovent Biologics’ Mazdutide Approved in China for Type 2 Diabetes
PremiumCompany Announcements
Innovent Biologics’ Mazdutide Approved in China for Type 2 Diabetes
5M ago
Innovent Biologics Grants Share Options to Boost Employee and Director Engagement
PremiumCompany AnnouncementsInnovent Biologics Grants Share Options to Boost Employee and Director Engagement
6M ago
Innovent Biologics Reports Strong Growth and Profitability
Premium
Company Announcements
Innovent Biologics Reports Strong Growth and Profitability
6M ago
Innovent Biologics Reports Strong Revenue Growth and Profitability in H1 2025
Premium
Company Announcements
Innovent Biologics Reports Strong Revenue Growth and Profitability in H1 2025
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >